Cita APA

A, M., S, C., E, C., A, A., M, T., C, N. C., . . . M, H. (2023). Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: A real-life multicentre analysis of 162 patients.

Citación estilo Chicago

A, Muñoz-Vendrell, et al. Effectiveness and Safety of Anti-CGRP Monoclonal Antibodies in Patients Over 65 Years: A Real-life Multicentre Analysis of 162 Patients. 2023.

Cita MLA

A, Muñoz-Vendrell, et al. Effectiveness and Safety of Anti-CGRP Monoclonal Antibodies in Patients Over 65 Years: A Real-life Multicentre Analysis of 162 Patients. 2023.